Bryn Pharma Completes Dosing in Pivotal Clinical Trial Designed to Support U.S. Approval of Intranasal Epinephrine Spray

Thursday, October 10, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Nasal Spray Product is Disruptive Innovation for People at Risk of Anaphylaxis



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store